PrEP Promise in Peril: Why America’s HIV Endgame Hits Barriers

PrEP could end HIV in the United States, but access remains uneven due to insurance gaps, provider knowledge gaps, stigma, and racial/geographic disparities; telemedicine and long-acting injections are expanding reach, but affordability and policy changes—like funding cuts to HIV prevention—could threaten progress.